Quality of life is an increasingly important endpoint in the therapeutic assessment and clinical trials of hypertension.
May inform hypertension decisions via quality-of-life focus; leaves open validation in higher-level trials.
Quality of Life is widely perceived to be an important end point in the therapeutic assessment. Quality of Life end points that are related to health are increasingly being used to adjust measures of effectiveness for clinical decision making, resource allocation and to evaluate drugs in clinical trials of hypertension.
No takes yet. Share an insight, caveat, or question.
Malhotra et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: